C. Lock

发表

The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease

Jorge R. Oksenberg, Sergio E. Baranzini, Lawrence Steinman, 2001, Science.

Response to Comment on "The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease"

R. Pedotti, S. Youssef, R. Sobel, 2003, Science.

The specificity of the antibody response in multiple sclerosis

H. Garren, L. Steinman, C. Lock, 1998, Annals of neurology.

Fluorescence-Activated Cell Sorter Analysis of Peptide–Major Histocompatibility Complex

H. Mcdevitt, A. Sinha, T. Mietzner, 1993 .

Inhibitory role for GABA in autoimmune inflammation

Melissa Miranda, Lawrence Steinman, R. Axtell, 2010, Proceedings of the National Academy of Sciences.

Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response.

L. Fugger, S. Michie, I. Rulifson, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Antigen Recognition and Peptide‐Mediated Immunotherapy in Autoimmune Disease

H. Mcdevitt, C. Lock, D. Smilek, 1990, Immunological reviews.

Immune Factors in Narcolepsy in the United Kingdom

K. Welsh, J. Parkes, C. Lock, 1988 .

HLA in Narcolepsy/Cataplexy in the United Kingdom

R. Vaughan, K. Welsh, J. Parkes, 1988 .

MHC class II sequences of an HLA-DR2 narcoleptic

J. Trowsdale, K. Welsh, J. Parkes, 2004, Immunogenetics.

Competitive inhibition of antigen presentation in animal models of autoimmune disease.

M. Vaysburd, C. Lock, A. Gautam, 1991, Seminars in immunology.

Narcolepsy and immunity.

J. Parkes, C. Lock, N. Langdon, 1986, British medical journal.

Immune factors in narcolepsy.

D. Vergani, K. Welsh, J. Parkes, 1986, Sleep.

Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides

H. Mcdevitt, M. Vaysburd, C. Lock, 1995, The Journal of experimental medicine.

Gene microarray analysis of multiple sclerosis lesions.

R. Heller, C. Lock, 2003, Trends in molecular medicine.

Heerfordt's syndrome with polyradiculopathy, a rare presentation of neurosarcoidosis: Case report and review of literature

M. Han, Neda Sattarnezhad, C. Lock, 2022, Neuroimmunology Reports.

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

Jorge R. Oksenberg, Naftali Kaminski, Lawrence Steinman, 2002, Nature Medicine.

Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis.

M Roederer, L A Herzenberg, D. Voehringer, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice

I. Weissman, S. Brownell, R. Sobel, 2012, The Journal of experimental medicine.

Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients

J. Trowsdale, J. Madrigal, D. Altmann, 1988, The Journal of experimental medicine.

Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM

Mark S. Anderson, J. Derisi, B. Ueberheide, 2022, Nature.

Genetic factors in sleep disorders.

J. Parkes, C. Lock, 1989, Journal of neurology, neurosurgery, and psychiatry.

Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity.

H. Mcdevitt, L. Steinman, C. Pearson, 1994, Proceedings of the National Academy of Sciences of the United States of America.

The role of TNFα and lymphotoxin in demyelinating disease

L. Steinman, J. Oksenberg, C. Lock, 1999 .

Progression of Mycosis Fungoides After Fingolimod Treatment for Multiple Sclerosis and Targeted Next-Generation Sequencing Demonstrating Potential Links Between the Two Diseases.

K. Rieger, A. Saleem, C. Lock, 2023, JCO precision oncology.

Selegiline in narcolepsy.

P. Jenner, J. Parkes, C. Lock, 1986, Sleep.

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

A. Bar-Or, D. Hafler, A. Cross, 2023, Proceedings of the National Academy of Sciences of the United States of America.

The role of TNFalpha and lymphotoxin in demyelinating disease.

L. Steinman, J. Oksenberg, C. Lock, 1999, Annals of the rheumatic diseases.

Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM

Mark S. Anderson, J. Derisi, B. Ueberheide, 2022, Nature.